Skip to main content
>

New molecular views of how neurons pace their signals

Detailed structural images reveal how an ion channel helps curtail a neuron’s firing. The work has relevance for diseases in which this molecule malfunctions.

A first look at the earliest decisions that shape a human embryo

For the first time, scientists have shown that a small cluster of cells in the human embryo dictates the fate of other embryonic cells. The discovery of this developmental “organizer” could advance research into many human diseases, and it suggests we have more in common with birds than meets the...

Gaby Maimon and Luciano Marraffini are named HHMI investigators

Maimon, who studies cognition and decision-making, and Marraffini, who studies the bacterial defense system CRISPR-Cas, are among 19 scientists nationwide to receive this designation.

Sohail Tavazoie promoted to professor

Sohail Tavazoie, a physician-scientist who studies the genes that regulate a tumor’s ability to metastasize, has been promoted to professor.

Rockefeller takes first place in global ranking of scientific impact

Out of over 900 universities from 55 different countries, Rockefeller tops a survey measuring the impact of university research publications, scoring the highest percentage of frequently cited scientific publications.

A new way to watch brain activity in action

A new imaging tool makes it possible to track the firing of millions of brain cells in mice while the animals move about as normal. The method could help shed new light onto the neural processes that create behavior.

Jeffrey V. Ravetch to receive 2018 Robert Koch Award

Ravetch receives the award for his groundbreaking work analyzing the immune system’s antibody response. He has worked for decades on the Fc fragment of the antibody molecule and its binding partners, known as Fc receptors.

>

New method allows scientists to study how HIV persists

Scientists have developed a new strategy to study the cells that host hidden reserves of dormant HIV, a step that may lead to new treatments that go beyond controlling the infection and instead aim to eradicate the virus entirely.

Small molecule from Kapoor lab is accepted as first Bridge Medicines drug candidate

A chemical inhibitor targeting basal cell carcinoma, originating from Tarun Kapoor’s lab, is graduating from the Tri-Institutional Therapeutics Discovery Institute into Bridge Medicines.

From infection-dodging stem cells, new tactics for research on viral disease

Among other superpowers, stem cells have a knack for fending off viruses like dengue and zika. Scientists have gained new insight into these curious defense strategies—knowledge they say could fuel the development of drugs against a range of diseases.